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October 18, 1982 We reported that an injection of chlor promazine (CPZ) into the lateral ventricle caused a transient decrease in serum FFA. The involvement of the central dopaminergic mechanism in this decrease was considered
(1). The dopaminergic-cholinergic an tagonistic relationship in the nigro-striatal system, indicated by metabolic (2-6), behavioral (6, 7) and microiontophoretical (8) evidence, is now well known. Therefore, in order to know the involvement of the central cholinergic system in the control of peripheral lipid mobilization after intra cerebroventricular (i.c.v.) injection of CPZ, we examined the effect of cholinergic agents on the change in the serum FFA level after the i.c.v. injection of CPZ in rats.
Male Wistar-lmamichi rats weighing 180 280 g were kept in an air-conditioned room (23±2°C, 55±5% humidity) lighted 14 hr a day (06:00 to 20:00) and maintained on a rat standard diet and water ad libitum. For injections into the cerebral ventricles, a stainless steel cannula was implanted into the right lateral ventricle under sodium pentobarbital anesthesia (nembutal, 40 mg/ kg i.p.). After a 7-day post-operative recovery period, drugs were injected through this cannula without any anesthesia. All i.c.v. injections of drugs were made in the same volume (20 ul/kg) over a period of 20 sec. All the drugs (CPZ hydrochloride: Shionogi Pharmaceutical Co. Ltd., acetylcholine (ACh) chloride: Daiichiseiyaku Co. Ltd., carbamyl choline (CAR) chloride: Sigma Chemical Co. Ltd., atropine sulfate: lwakiseiyaku Co. Ltd., neostigmine methyl sulfate: Shionogi Phar maceutical Co. Ltd.) were dissolved in saline, and the solution was adjusted to a pH of 6.8. All doses of drugs used are given in the results as the amount of free base. Blood samples for determination of FFA were obtained from the jugular vein of rats with a disposable syringe. Serum FFA was deter mined colorimetrically according to the method of Novak (9).
As is described in the previous report (1), the i.c.v. Injection of CPZ produced a marked transient decrease in serum FFA with the two doses (200, 500 ug/kg) examined, whereas the same volume of vehicle (20 ul/kg) had no effect. Serum FFA levels reached a minimum 30 min after injection of CPZ and then returned to the initial level during the second hour. With a lower dose of 100 ug/kg CPZ, only a slight decrease was observed, but this was not statistically significant. Micro injection of either ACh alone at a dose of 20 ug/kg or carbachol at the same dose did not affect the serum concentration of FFA. The simultaneous administration of ACh and CPZ at 100 ug/kg into the right lateral ventricle accelerated the fall in the serum FFA level, whereas the simultaneous admin istration of ACh with two higher doses of CPZ (200 or 500 ,ag/kg) did not show any modification. On the other hand, the fall in the serum FFA level after CPZ at 100 or 200 ug/kg i.c.v. was significantly accelerated with the simultaneous injection of 20 ag/kg carbachol. However, at a dose of 500 ug/kg i.c.v. CPZ, the significant modification following the simultaneous injection of carbachol was not observed. The potentiation by carbachol of CPZ was more pronounced and long-lasting than that of ACh (Fig. 1) .
Further, in an attempt to examine the effect of an anticholinergic agent and anticholi nesterase, 50 Jag/kg atropine or 5 ,ag/kg neostigmine was injected intracerebroven triculary 10 min prior to the injection of CPZ, ACh and carbachol. As shown in Fig. 2 , the potentiation by simultaneous injection of ACh with 100 fig/kg CPZ was significantly blocked by the prior i.c.v. injection of atropine, indicating that muscarinic synaptic receptors are involved in this effect. However, the potentiation by carbachol was hardly inhibited by preinjection of atropine, suggesting that the mechanisms of the potentiation by carbachol may be different from that by ACh. After the i.c.v. injection of 5 ag/kg neostigmine, the tendency of the opposite response in the potentiation of CPZ action by these two cholinergic agents (ACh, car bachol) was observed, even though it was not significant. These results after preinjection of atropine or neostigmine suggest that carbachol produced the potentiation of CPZ action as well as ACh; but the details of the mechanisms of the action by this drug is probably different from ACh, i.e., the possible involvement of the muscarinic cholinergic receptors in the potentiation by ACh of CPZ action was revealed, but presumably not in the potentiation by carbachol.
On the other hand, it has been already demonstrated that there is an antagonistic relationship between the dopaminergic and cholinergic system in the striatum (2-8), although it remains still controversial whether nigro-striatal dopamine neurons exert an excitatory (10, 11) or inhibitory (2, 12) effect on cholinergic interneurons in the striatum. (2, 4, 13, 14) . In this experiment herein, the effect of CPZ on the decrease in serum FFA was potentiated by the cholinergic agents such as ACh and carbachol. On the contrary, this effect was blocked by dopamine and apo morphine as described in our previous report (1). Now, a possible cholinergic involvement in the control of peripheral lipid mobilization induced by CPZ is also suggested. It is therefore possible to say that the central dopaminergic-cholinergic system is involved in the peripheral lipid mobilization induced by CPZ.
